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SUMMARY
Objective: To determine the relationship between metabolic syndrome (MS) and socio-
economic level, life style, health status, family history of morbidity, and residence areas. 
Methods: This is a cross-sectional cohort study. The random sample consisted of users of 
two primary healthcare units (Unidades Básicas de Saúde - UBSs) in the city of São Paulo 
— Jardim Comercial (UBS1), and Jardim Germânia (UBS2), a total of 452 subjects. The 
NCEP ATP III criterion was used to diagnose MS. Weight, height, abdominal and hip cir-
cumferences were measured for the anthropometric evaluation. A general questionnaire 
was used to obtain sociodemographic and socioeconomic data; family history; medical 
history; behavioral habits such as smoking, drinking, and physical activity. Multivariate 
logistic regression was used to establish the association between explanatory variables of 
interest and MS. Results: At UBS1, MS percentage was 56.1%; at UBS2, 34.0%. There was 
a direct and significant association between MS and age, female gender, race, smoking, 
drinking, physical activity level, stress, and family history of heart disease and diabetes 
mellitus. Education level showed an inverse association. Subjects living in a lower socio-
economic level neighborhood had a higher MS risk. Conclusion: The results suggest that 
the morbidities that compose MS are a serious public health problem in that population.
Keywords: Socioeconomic factors; healthcare centers; primary healthcare; diabetes mel-
litus type 2; psychological stress; dyslipidemias.
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INTRODUCTION
Metabolic syndrome (MS) has turned into one of the 
greatest challenges in public health these days. Estimates 
show that 20 to 25% of the world adult population possibly 
has MS, which raises the risk of death by two times, the 
risk of a heart attack and stroke by three times, and the risk 
of developing type 2 diabetes by five times1-3.
As a result of new life style characteristics, the popula-
tion is growing obese, which contributes to alterations of 
the neuroendocrine mechanisms involved in controlling 
body weight, thus increasing MS prevalence4 The varied 
consensus on MS criteria result in many dierent preva-
lence estimates. Nevertheless, a MS increase is observed 
in industrialized and developing countries. In population 
studies, it is estimated to aect between 20.5% and 26.7% 
of adults in the United States5-8. Other authors report a 
prevalence from 19.8% to 24% in Europe9,10. In some areas 
of Brazil, the prevalence is found to be between 18% and 
30%, with MS occurrence being more evident in older age 
groups11-15.
Other population studies report a prevalence for Mexi-
can, American, and Asian populations ranging between 
12.4% and 28.5% among males and from 10.7% to 40.5% 
among females16-18.
In a cross-sectional population study conducted in 
Novo Hamburgo, RS, Brazil, MS prevalence was 50.3%, ap-
plying the NCEP ATP III diagnostic criteria. The progres-
sive increase in MS prevalence occurred in both genders, 
with a higher prevalence among females, for whom the 
percentage was 57.1%, while 36.5% was found in males19.
In a population study in Vitória, ES, MS was identi-
fied considering parameters defined by the First Brazilian 
Guideline for Metabolic Syndrome Diagnosis and Treat-
ment, which was based on the criteria defined by the Na-
tional Cholesterol Education Program’s – Adult Treatment 
Panel III (NCEP – ATP III)20. The overall MS prevalence 
in the study sample was 29.8%, with no gender dierences 
in individuals aged 25 to 64 years14.
In the period from 2004 to 2005, a study with a cohort 
from Pelotas, RS, of individuals born in 1982, found a MS 
prevalence of 5.9% by the NCEP ATP III criterion. Among 
men, BMI (overweight and obesity) was associated with 
MS. Among women, family income and education level 
were inversely associated with MS; overweight and obesity 
increased MS risk21.
As in population studies, those conducted in specific 
groups of patients having diabetes, hypertension, and dys-
lipidemias as cohorts that require care in primary health-
care units, found the prevalence to be quite variable, rang-
ing from 27% to 87%22-33 MS is also associated with low 
education level, social inequality, social isolation, psycho-
social stress, dietary patterns, physical activity, drinking, 
and smoking34.
Insulin resistance, abdominal obesity, hypertension, 
and low HDL-cholesterol levels are considered MS-de-
fining factors. Genetic inheritance, physical inactivity, 
age, a proinammatory status, and hormone changes can 
also have a determining eect, but their role can vary, 
depending on the ethnic group34.
The current study assumes that lifestyle and quality 
of life are key factors in determining MS and can pro-
vide a basis for intervention programs. Thus, we aimed 
at finding a relationship between MS and the users of 
two primary healthcare units in the Southern area of São 
Paulo, each of them having dierent socioenvironmental 
profiles.
METHODS
LOCATION
The study was conducted at the Local Health Department 
of the city of São Paulo, Southern Regional Health Coor-
dination, Campo Limpo Health Supervision, in two pri-
mary healthcare units: UBS in Jardim Comercial (UBS1) 
and UBS in Jardim Germânia (UBS2), where all study 
steps phases were developed.
These neighborhoods were intentionally chosen as a 
sample consisting of unique socioeconomic profiles in 
order to capture the eect that dierent lifestyles would 
produce on MS: Jardim Comercial has a low socioeco-
nomic level population and a poor environment, many 
streets are not paved, there are many alleys, part of the 
population has poor sanitation, with areas of the neigh-
borhood displaying open sewage and garbage dumped in 
inappropriate spots. In Jardim Germânia, middle class 
and lower middle class predominate, the environment 
has a higher quality, there are water supply, sewage ser-
vice, public transportation, and other resources, such as 
paved streets, private schools, and developed commercial 
establishments, including a shopping mall.
DESIGN
This is a cross-sectional study in an adult representative 
community sample that considered the proportionality 
of the two UBSs. This is a part of the Metabolic Syndrome 
and Stress Study in the population registered in two pri-
mary healthcare units located in the Southern zone of 
São Paulo.
SAMPLE
A database was designed from the hard copies of the 
medical records of families registered in the UBSs, cover-
ing all individuals aged 20 years and over.
The subjects were selected via ticket sampling, ac-
cording to a sample plan stratified (neighborhood) by 
conglomerate (families) into two levels: 1st level, the fam-
ily; 2nd level, the individual.
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The number of families to be ticket sampled in each 
UBS was calculated in proportion to the family size. In 
each UBS, the families were selected by a simple random 
process. In each family, a user was also selected by a simple 
random process.
According to the defined sampling plan and consider-
ing an estimated total MS prevalence of 22% and an accu-
racy level of 5%, the sample size was 592 users: 342 in area 
1 and 250 in area 2, representing one individual in each 
registered family. 140 individuals (23.6%) did not join the 
study, most of them being males. However, the service user 
profile was maintained and consisted mostly of females.
INCLUSION AND EXCLUSION CRITERIA
Both physically disabled and unable to walk patients, as 
well as pregnant and nursing women, were excluded.
ETHICAL ISSUES
All selected subjects were informed about the study and 
those who agreed to participate were given a written in-
formed consent statement to sign, according to the CNS 
(National Board of Health) Resolution 196 of October 10, 
1996.
The project was submitted to and approved by the 
Committees of Ethics in Research with Humans of the 
Public Health School of the Universidade de São Paulo and 
that of the local health department.
DEFINITION CRITERIA FOR METABOLIC SYNDROME
MS was defined as the simultaneous presence of 3 to 5 of 
the following metabolic risk factors in one patient: waist 
circumference > 102 cm for men and > 88 cm for women; 
triglycerides  150 mg/dL; HDL-cholesterol < 40 mg/dL 
for men and < 50 mg/dL for women; blood pressure > 
130/85 mmHg; fasting blood glucose  110 mg/dL, ac-
cording to the Third Report of the National Cholesterol 
Education Program Expert Panel on Detection, Evalua-
tion and Treatment of High Blood Cholesterol in Adults 
(NCEP-ATP III) of 200135,36.
The I Brazilian Guideline for MS Diagnosis and Treat-
ment of 2005 uses the 2001 NCEP ATP III criteria for di-
agnosis. Thus, we adopted these criteria in our study.
CLINICAL AND BIOCHEMICAL INQUIRIES
The selected individuals were convened through an invita-
tion letter by the Health Community Agents in every mi-
croarea where a selected individual could be found. The 
patient was oáered the opportunity to choose the date and 
time for his/her interview.
The interviews for application of the questionnaire, 
physical measurements, and blood collection were per-
formed in the two primary healthcare units by the study 
author and her team, consisting of students of psychology, 
nutrition, physical education, and nursing, as well as a 
psychologist. The interviewers were properly trained in 
the Nutrition Outpatient Clinic of the Centro Universi-
tário Adventista de São Paulo between March and April of 
2008. Nursing assistants from both UBSs participated in 
data collection (blood pressure measurement), aá er being 
instructed to use the blood pressure measurement  proce-
dure recommended by the V Brazilian Guidelines of Arte-
rial Hypertension37. 
As the interviews were performed, the study objective 
and its relevance for Public Health were elucidated, and 
the patient’s agreement to participate was recorded by an 
informed consent statement. Throughout the interviews, 
the subjects were granted a statement justifying their ab-
sence from work in order to participate in the study.
 The data collection took place in two stages. In the first 
stage, the following tools were applied:
– General Questionnaire recording data required 
in the study: sociodemographic, clinical, and bio-
chemical data; family history, drinking and smok-
ing status, anthropometric data, blood pressure 
measurements etc.
– Lipp’s Inventory of Stress Symptoms for Adults 
(ISSL)38.
– International Physical Activity Questionnaire 
(IPAQ), modified long version, leisure-time and lo-
comotion/transportation domains, along with the 
System of Risk Factor Vigilance and Disease Pro-
tection questionnaire (Sistema de Vigilância de Fa-
tores de Risco e Proteção para Doença - VIGITEL), 
work and household domains39,40.
– A questionnaire on the degree of physical activ-
ity according to a WHO criterion (1985), which 
was defined as a multiple of the basal metabolism 
rate41.
– CAGE questionnaire with two categories evaluat-
ing alcohol abuse risk42.
The second stage of data collection consisted of sample 
collection for blood chemistry tests. The patients were in-
structed about the required 12-hour fast.
STATISTICAL ANALYSIS
An association between the explanatory variables of inter-
est and metabolic syndrome was established by multivari-
ate logistic regression analysis. The explanatory variables 
of interest were age (20-29, 30-39, 40-49, 50-59, 60-69, 
and > 70), gender (male or female), marital status (single, 
married or living with a partner, divorced/separated, wid-
owed), education level (illiterate/incomplete elementary I 
level – less than 4 years; complete/incomplete elementary 
II level – 4 to 8 years; complete/incomplete secondary lev-
el; complete/incomplete higher level), family income (< 1 
minimum wage (MW), 2 < 5 MW, 5 < 10 MW, > 10 MW), 
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smoking (yes/no), alcohol abuse risk (yes/no), physical 
activity level according to WHO (sedentary, mild, mod-
erate, high activity level) and IPAQ/VIGITEL (sedentary 
person, active person, very active person) criteria, obesity 
(BMI > 30 mg/kg2), stress (yes/no), race (white, mixed race 
or black, Asian), family history of hypertension (yes/no), 
family history of heart disease (yes/no), family history of 
diabetes (yes/no).
The SUDAAN statistical soware was used, incorpo-
rating the sampling plan structure into the analysis, as this 
sample had a stratification and conglomerates.
The univariate logistic regression between the explana-
tory variables above and MS was calculated, aiming to 
identify which variables would be a part of the univariate 
model.
The significance level adopted was 5%. The statistics 
with a p-value  0.05 were considered significant.
– Adjustment of models in logistic regression
– Chi-square test for likelihood -2 log value change. 
The critical (significant) p-value in the ultimate 
model must be < 0.05.
– Hosmer Lemeshow test:  a good model adjustment 
is indicated by a non-significant chi-square value 
(at least p > 0.10).
Either the presence or the absence of multicollinearity 
was tested in every model by employing multicollinearity 
diagnosis criteria.
RESULTS
Table 1 shows that most subjects were females: at UBS1, 
the percentage was 67.4% and at UBS2, 59.2%. The age 
group most represented was the 40-49 years for both gen-
ders at the two UBSs, 26.4% and 21.4%, respectively.
Regarding the years of education of the study popula-
tion in both groups, UBS1 and UBS2, elementary level 
predominated, 81.5% and 78.1%, respectively. UBS1 had 
higher values for illiterates, and UBS2 had higher values 
for secondary and higher education. Most subjects were 
married or lived with a partner.
Based on data of family income between 1 and 5 MW, 
66.4% of the subjects from UBS1 and 57.8% of subjects 
from UBS2 were observed to live on this income. On 
the other hand, UBS2 had more subjects (9.1%) with a 
family income higher than 10 MW. By comparing the 
families living with less than 1 MW between the UBSs, 
a higher percentage can be found from UBS2. The sur-
vival strategies between neighborhoods are assumed to 
be different, i.e., at UBS1, families may be favored by 
social projects, e.g., a family subsidy (bolsa-família), 
among others.
At UBS1, there was a higher percentage of non-white 
subjects participating in the study. Lower income and 
education level were also observed.
Concerning behavioral habits, similar values were 
found at both UBSs: smoking at UBS1, 17.7%; at UBS2, 
18.2%; alcohol abuse at UBS1, 6.0%; at UBS2, 4.8%.As for 
the classification of physical activity level according to 
WHO criteria, UBS2 had dierent percentages than UBS1 
in almost every level, evidencing sedentarism. According 
to the IPAQ/VIGITEL criteria, the majority of population 
in both UBSs had high indexes of inactivity, 87%.
Table 2 shows the number and percentage of people 
with metabolic syndrome, stress, obesity (BMI) and family 
history of hypertension, heart disease, and diabetes.
The percentage of subjects having MS is 56.7% at UBS1 
and 34.0% at UBS2. Overweight was higher at UBS2, 
41.2%, and obesity was higher at UBS1 (39.6%). High 
stress prevalence was found for both UBSs: 56.9% at UBS1, 
and 85.6% at UBS2.
Approximately half the study population had family 
history of hypertension, heart diseases, and diabetes.
A univariate model was initially designed to find out 
the associations between MS and the proposed variables. 
Variables suitable for entering the multivariate model 
showed a p-value  0.05. They were successively and se-
quentially added to the multivariate model by testing the 
presence of interaction. Changes in the OR magnitude 
over 10% are generally indicative of confounders (Table 3).
Table 4 shows associations between MS and sociode-
mographic, socioeconomic, and biological factors.
Subjects in the 50-59 age group were 8 times more 
likely to have MS (OR = 7.779; p < 0.001) and those in 
60-69 age group, 11 times (OR = 10.945; p < 0.001). The 
extremes — the youngest and the oldest individuals — 
had lower chances. Females were 1.8 times more likely to 
have MS (p < 0.001). Non-white were 1.3 times more likely 
(p < 0.001), compared to white people. The education level 
was inversely related (p < 0.001).
As for behavioral habits, smokers were 4 times more 
likely (p < 0.001) to have MS, compared to non-smokers. 
Regarding the alcohol abuse risk factor, the association 
was also significant (OR = 1.459; p < 0.001).
In turn, living in the poor neighborhood with a low 
socioeconomic level – UBS1 – means having 2.3 times the 
risk for MS (p < 0.001).
Living a stressful life significantly raises the risk for MS 
(p = 0.006) in subjects from both neighborhoods.
Associations were also significant for individuals with 
a family history of hypertension and diabetes (p < 0.001 
for both variables).
Inactivity and a low level of physical activity signifi-
cantly raise the population risk for (p < 0.001) MS, when 
compared to moderate and high levels of physical activity.
In association evaluations, the waist-hip ratio was re-
moved from the models due to the multicollinearity with 
the abdominal circumference.
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Characteristics
UBS1 UBS2 Total
n % n % n %
Age (years)        
20-29 50 18.9 19 10.2    69 15.3
30-39 42 15.8 30 16.0    72 15.9
40-49       70 26.4 40 21.4  110 24.3
50-59 44 16.6 38 20.3    82 18.1
60-69 39 14.7 34 18.2    73 16.2
≥  70      19 7.2 26 13.9    45 10.0
Gender            
Female 157 59.2 126 67.4 283 62.6
Male 108 40.8  61 32.6   61 32.6   
Race            
White 108 40.8 104 55.6   104 55.6   
Non-White 152 57.4   83 44.4   235 52.0
Marital status            
Single   57 21.5  32 17.1    89 19.7
Married/living with a 
partner
154    58.1      110 58.8   264 58.4
Divorced/separated 29 10.9  23 12.3    52 11.5
Widowed    19  7.2  19 10.2    19 10.2    
Education level (years)            
Illiterate  23 8.7 13 7.0     36 8.0
Elementary    216 81.5     146 78.1   362 80.1
Secondary 18 6.8 22 11.8     40 8.8
Higher     5 1.9  6 3.2     11 2.4
Family income            
< 1 minimum-wage 3 1.1 6 3.2      9 2.0
1  <  5 minimum-wages       176 66.4    108 57.8  284 62.8
5  <  10 minimum-wages 38  14.3      37 19.8    75 16.6
≥ 10 minimum-wages  9 3.4      17 9.1    26 5.8
Smoking status            
Smoker   47 17.7 34 18.2 34 18.2
Non-smoker 203 76.6 127 67.9  330 73.0
Former smoker 15 5.7 24 12.8    39 8.6
Alcohol abuse risk            
Yes   16 6.0 9 4.8 25 5.5
No 249 94.0  178 95.2    427 94.5
Physical activity (WHO)            
Inactivity 92 34.7   99 52.9   191 42.3
Mild 74 27.9   51 27.3   125 27.2
Moderate 88 33.2  32 17.1   120 26.5
High (IPAQ/VIGITEL)
Active 11 4.2    5 2.7 16 3.5
Inactive 33 12.5  22 11.8 55 12.2
Table 1 – Sociodemographic, socioeconomic, and behavioral characteristics of UBS population in study areas, São Paulo – SP, 
Brazil, 2009
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According to IPAQ and VIGITEL criteria, physical 
inactivity values were higher and similar in both neigh-
borhoods. But they were not entered into the multiple 
regression analysis, as they revealed very high descriptive 
level (p).
DISCUSSION
This study supports the findings showing a close relation-
ship between social and psychosocial factors, family his-
tory of diabetes, hypertension, heart disease and the meta-
bolic syndrome. It suggests poverty is a risk factor for MS, 
as a direct and significant association was found between 
this morbidity and education level, socioeconomic level, 
and place of residence.
Similar results were found in a population basis study 
from Vitória, ES, Brazil, revealing MS prevalence accord-
ing to socioeconomic stratification. In class A, the preva-
lence was 29.6% for males and 17.9% for females, whereas, 
in classes D and E, the prevalence was 25.3% for males and 
38.7% for females. In this analysis, classes D and E were 
merged. There was a trend of increased MS prevalence 
in lower socioeconomic strata. This increase was due to 
the class inuence on MS distribution found in females, 
since the presence of women with MS was twice higher in 
classes D and E (38.7%) than in class A (17.9%)14. Lidfeldt 
et al.34, also found an association of MS with low educa-
tion level, social inequality, social isolation, psychosocial 
stress, dietary patterns, physical activity, alcohol abuse, 
and smoking.
Regarding the race eect on MS, studies are inconclu-
sive; in this study population, poor areas are assumed to 
have a population with a low level education, concentrat-
ing a larger number of non-white, mixed race, and black 
individuals, thus showing a higher MS chance in non-
white people.
In a cross-sectional study conducted in a population 
subgroup in Salvador, BA, Brazil, a self-definition of race 
(white, mixed race, black) and the ATP-III MS criterion 
were used. The general MS prevalence, adjusted for poten-
tial confounders, was not dierent among white (23.3%), 
mixed race (23.3%), and black individuals (23.4%). In 
multivariate analysis on the association between race and 
MS (white individuals = reference group), being afro-
descendent, among men, was a protection factor, whereas 
this tended to be a risk factor among women43.
In a study by Salaroli14, conducted in Vitória, ES, Bra-
zil, the economic class eect on MS prevalence distribu-
tion was observed as seemingly unrelated to the inuence 
on education level. In men, the education level did not 
aect the prevalence. In women, despite the significant 
Category
UBS1 UBS2 Total
n % n % n %
Metabolic syndrome          
Yes 149 56.2 65 34.0 214 47.3
No 116 43.8 122 65.2 238 52.7
BMI            
Normal and malnourished 73 27.5   57 30.5 130 28.8
Overweight  87 32.8 77 41.2   164 36.3
Obese  105 39.6  53 28.3  158 35.0
Stress            
Yes 151 57.0    143 85.6 294 65.0
No 114 43.0 44 23.4 158 35.0
Family history of hypertension            
Yes   145 64.2   117 62.6   287 63.5
No 70 26.4    44 23.5   44 23.5   
Family history of heart disease            
Yes  121 45.7    86 46.0   207 45.8
No  122 46.0     80 42.8   202 44.7
Family history of diabetes            
Yes  139 52.5 139 52.5     224 49.6
No 105 39.6 83 44.4   188 41.6
Table 2 – MS presence, stress, and family history of hypertension, heart disease, and diabetes, São Paulo – SP, Brazil, 2009
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Variable Sample  OR 95% CI p
Age
20-29 69 1.00    
30-39 72 2.23 1.60; 3.15 < 0.001
40-49 110 3.77 2.77; 5.14 < 0.001
50-59 82 7.78 5.70; 10.6 < 0.001
60-69 73 10.9 8.05; 14.9 < 0.001
70 + 45 3.31 1.39; 14.5 < 0.001
Gender
Male 172 1.00    
Female 285 1.78 1.40; 2.41 0.033
Race
White 212 1.00    
Non-White 235 1.35 1.27; 1.50 < 0.001
Marital status
Single 89 1.00    
Married/living with a partner 264 0.84 0.34; 2.07 0.221
Divorced/separated 52 1.35 0.61; 3.00 0.702
Widowed 38 1.77 0.68; 4.58 0.242
Education level
Education years   0.80 0.72; 0.91 0.013
Neighborhood
J. Germânia 187 1.00    
J. Comercial 265 2.37 1.56; 3.60 < 0.001
Smoking status
Non-smoker 81 1.00    
Smoker 369 3.76 2.12; 4.71 0.05
Alcohol abuse
No 427 1.00    
Yes   25 1.36 1.05; 1.72 0.003
Physical activity (WHO)
Inactivity 191 2.19 1.23; 3.83 0.006
Mild 125 2.18 1.30; 3.65 0.003
Moderate/high  136 1.00    
Stress
No 148 1.00    
Yes 304 1.10 1.01; 1.23 0.05
Family history of hypertension
No 152 1.00    
Yes 287 1.51 1.34; 1.71 0.05
Family history of heart disease
No 202 1.00    
Yes 207 1.08 1.01; 1.29 0.05
Family history of diabetes
No 188 1.00    
Yes 224 1.37 1.13; 1.51 0.001
Table 3 – Univariate analysis between metabolic syndrome and socioeconomic risk factors
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eect on the education level (p < 0.05), no regular trend 
of prevalence was observed as a function of this factor. MS 
prevalence was similar among dierent ethnic and racial 
groups.
Physical inactivity was higher at UBS Jardim Germâ-
nia, and this may be attributed to the kind of occupational 
activity of the residents in this neighborhood, since they 
have a higher education level, compared with the residents 
in Jardim Comercial and, therefore, their occupational ac-
tivities would be less strenuous.
The population in Jardim Germânia is likely to have 
better means of locomotion than that in Jardim Comer-
cial, as well as activities that require less physical eort. 
Florindo et al.44, in a prevalence study among São Paulo 
population, evaluated physical inactivity and found a 
high prevalence related to locomotion, followed by lei-
sure time, work and household activities44. Increased 
physical activity and reduction of body weight greater 
than 5% of the starting value acted favorably on every 
MS element37,39.
Variable ȕ OR 95% CI p
Age (years)        
20-29  = 0   1.00        
30-39 = 1 0.805 2.236 1.589-3.147 < 0.001
40-49 = 2 1.327 3.771 2.766-5.140 < 0.001
50-59 = 3 2.051 7.779 5.702-10.614 < 0.001
60-69 = 4 2.393 10.945 8.045-14.889 < 0.001
≥ 70 = 5 1.196 3.307 2.393-4.568 < 0.001
Gender        
Male = 0 1.00      
Female = 1 0.637 1.890 1.683-2.122 < 0.001
Race        
White = 0 1.00      
Non-White = 1 0.291 1.337 1.205-1.485 < 0.001
Education level (years)* -0271 0.805 0.721; 0.899 < 0.001
Smoking        
No = 0   1.00    
Yes = 1 1.359 3.891 3.236-4.679 < 0.001
Alcohol abuse        
Não = 0   1.00    
Sim = 1 0.378 1.459 1.157-1.842 < 0.001
Physical activity        
Inactivity = 1 0.234 1.276 1.120-1.453 < 0.001
Mild = 2 0.269 1.309 1.150-1.489 < 0.001
Moderate/high = 0   1.00    
Neighborhood        
Area 1 = 0   1.00    
Area 2 = 1 0.861 2.365 2.117-2.643 < 0.001
Stress        
No = 0   1.00    
Yes = 1 0.151 1.163 1.045-1.295 0.006
Family history of hypertension        
No = 0   1.00    
Yes = 1 0.415 1.514 1.340-1.710 < 0.001
Family history of heart disease        
No = 0        
Yes = 1 0.074 1.077 0.972-1.194 0.175
Family history of diabetes        
No = 0   1.00    
Yes = 1 0.301 1.351 1.221-1.496 < 0.001
Table 4 – Association between metabolic syndrome and sociodemographic, behavioral, socioeconomic, and biological 
variables in area 1 and area 2, São Paulo – SP, Brazil, 2009
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The alcohol abuse risk, evaluated by the CAGE ques-
tionnaire, was positively associated with MS. Lima et 
al.45 analyzed the alcohol abuse risk in workers at an 
oil refinery. They found a higher hypertension risk in 
CAGE-positive subjects compared with abstemious 
or CAGE-negative subjects.
Smoking was positively associated with MS, thus con-
firming the findings by Koster et al.46 in Diet and Study, 
a follow-up (1996-2006) with 237,868 participants, cover-
ing six states in the United States. The authors found that 
smoking was strongly associated with abdominal fat depo-
sition. These two factors, when in combination, increased 
the risk of death from diseases such as cancer, coronary 
artery disease, cerebrovascular accident, diabetes, pulmo-
nary emphysema and kidney disease by five times.
Another important finding from this study regards the 
higher overweight prevalence in Jardim Germânia, likely 
resulting from the high physical inactivity found. However, 
obesity was more prevalent in Jardim Comercial, possibly 
due to the obesogenic environment and conditions of life.
It is important to point out that several determinants 
resulting from poverty comprise MS etiology, such as prior 
malnutrition and obesogenic environments, in which high-
energy foods prevail due to their lower cost47,48. Neumann et 
al.49, in a study on eating patterns in the city of São Paulo, reg-
ister that fruit and vegetable intake is restricted to the popula-
tion of areas with higher socioeconomic and education level.
This study also confirms the importance of genetic 
factors for MS etiology. Family history of hypertension, 
diabetes mellitus and heart disease were found to associate 
significantly with MS.
Obesity, hypertension, hyperlipidemia, and high blood 
glucose raise the risk of developing diabetes and cardio-
vascular disease, and this factor combination comprises 
MS. The early identification of MS characteristics oers 
the opportunity for lifestyle interventions, prevention, and 
treatment. The early adoption by the whole population of 
lifestyles of health maintenance, such as healthy eating 
habits, physical exercises, smoking cessation, blood pres-
sure management, and weight loss can reduce metabolic 
risk factors2,3,20,34,50,51,52.
Stress showed a highly significant relationship with 
MS. Further studies on psychological factors associated 
with MS are of fundamental relevance for a more compre-
hensive understanding of this disease.
Under stress, the hypothalamo-hypophyseal-adrenal 
system is activated, leading to higher cortisol production, 
with increased fat deposition in the abdomen53,54.
Excessive stress can bring countless consequences to 
the individual, his/her family, the company he/she works 
for, and the community where he/she lives, including, but 
not limited to a decrease in productivity, anxiety, depres-
sive mood, mental fatigue, apathy, and diseases – such as 
arterial hypertension, diabetes, and obesity, among others. 
Life quality is compromised.54-56  
The results of this study can be applied to groups where 
conditions found are similar and where the characteristics 
identified in the study population can be reproduced. It 
points to the importance of healthcare services acting 
upon the need for activities related to mental health.
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